Proteomic Identification of Interleukin-2 Therapy Response in Metastatic Renal Cell Cancer

INTRODUCTION: To detect a predictive protein profile that distinguishes between IL-2 therapy responders and non-responders among metastatic RCC patients we used surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI TOF-MS). MATERIALS AND METHODS: Protein extracts of 56...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jones, Jon, Otu, Hasan H., Grall, Franck, Spentzos, Dimitrios, Can, Handan, Aivado, Manuel, Belldegrun, Arie S., Pantuck, Allan J., Libermann, Towia A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2007
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3836557/
https://ncbi.nlm.nih.gov/pubmed/18082202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2007.09.016
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi